Gates Package — page 49
of 1375 pages
← p.48 p.50 → · this page in the original PDF · package
meeting next week, as well as who from NIH is planning on attending. She's interested in arriving at
acommon
USG policy position prior to the meeting.
>
> I'm sure you're tied up with Clinical Center activities at the moment. Nicki is somewhat anxious. Anything I
can relate?
>
> Michael G Kurilla, MD-PhD
> Director, Office of BioDefense, Research Resources, and Translational
> Research Associate Director for BioDefense Product Development DMID,
> NIAID, NIH, DHHS
> 5601 Fishers Lane 8G61
> Rockville, MD 20852
zz
> The truly unusual day would be a day when nothing unusual happens.
> - Persi Diaconis
>
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/49
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| Status of Master Protocol & Geneva meeting | 2014-10-16 | 48–52 |